Related Experiment Video
Updated: Aug 25, 2026

Quantifying Myeloperoxidase-DNA and Neutrophil Elastase-DNA Complexes from Neutrophil Extracellular Traps by Using a Modified Sandwich ELISA
Published on: May 12, 2023
[Research progress of neutrophil extracellular traps in septic coagulopathy]
1Department of Laboratory Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China.
Insights
Neutrophil extracellular traps (NETs) drive sepsis-induced coagulopathy (SIC) by damaging blood vessels and disrupting clotting. Targeting NETs may offer new diagnostic and therapeutic strategies for this critical condition.
Area of Science:
- Critical care medicine
- Hematology
- Immunology
Background:
- Sepsis-induced coagulopathy (SIC) is a severe complication in intensive care, linked to high mortality.
- Vascular endothelial cell injury and coagulation dysfunction are key pathological mechanisms in sepsis.
- Neutrophil extracellular traps (NETs) are implicated in various inflammatory and infectious diseases.
Purpose of the Study:
- To review the mechanistic role of NETs in the pathogenesis of SIC.
- To discuss the potential of NETs as diagnostic biomarkers for SIC.
- To explore NETs as therapeutic targets for managing SIC.
Main Methods:
- Literature review of studies investigating NETs and SIC.
- Analysis of mechanisms linking NETs to endothelial damage and coagulation imbalance.
- Synthesis of current research on NET-based diagnostics and therapeutics.
Main Results:
- NETs contribute to SIC by causing vascular damage and promoting immunothrombosis.
- NETs disrupt the balance between coagulation and fibrinolysis in sepsis.
- Evidence suggests NETs play a central role in SIC development.
Conclusions:
- NETs are crucial mediators in the development of sepsis-induced coagulopathy.
- NETs show promise as potential biomarkers for early diagnosis of SIC.
- Targeting NETs represents a potential therapeutic strategy for SIC.
Abstract:
Sepsis-induced coagulopathy (SIC) ranks among the most dangerous coagulation disorders in intensive care units, with an incidence rate of up to 67.9% in China. This high mortality is mainly attributed to vascular endothelial cell injury and coagulation dysfunction caused by sepsis. Neutrophil extracellular traps (NETs) are reticular complexes formed by activated neutrophils in infected organisms through the release of DNA, proteases, cytokines, and other components. Recent studies have demonstrated that NETs can trigger systemic hemostatic imbalance in sepsis patients by mediating vascular endothelial damage, promoting immunothrombosis, and disrupting the coagulation-fibrinolysis balance, ultimately leading to the development of SIC. Therefore, this article reviews the mechanistic role of NETs in SIC and discusses recent advances in their potential as diagnostic biomarkers and therapeutic targets.
More Related Videos
09:59A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
Published on: January 29, 2019
11:32Real-Time, High-Throughput Microscopic Quantification of Human Neutrophil Extracellular Trap Release and Assessing the Pharmacology of Antagonists
Published on: October 18, 2024